Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044483989> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2044483989 endingPage "20" @default.
- W2044483989 startingPage "20" @default.
- W2044483989 abstract "Advanced high strength steels (AHSS), specifically dual phase (DP) steels, are extensively used to reduce the weight of vehicles. Fiber laser welding (FLW) has been shown to provide welds with superior mechanical properties made at high welding speeds. Galvannealing (GA) and galvanizing (GI) coated sheet steels are extensively used for auto bodies to improve corrosion resistance. As such, the effect of coating type on the microstructure, mechanical properties and fatigue properties of FLW similar joints of DP980 was assessed. There existed spherical tempered martensite in the GA coated DP980 base metal (BM), most likely caused by the galvannealing process. Coating type did not present a noticeable effect on the microstructure of the welded zones. The GI coating, however, could evaporate violently during welding, resulting in high concavity and other welding defects which negatively affect the high-cycle fatigue property. Measures to mitigate the negative effects of the GI coating were discussed." @default.
- W2044483989 created "2016-06-24" @default.
- W2044483989 creator A5008593691 @default.
- W2044483989 creator A5011327480 @default.
- W2044483989 creator A5013955755 @default.
- W2044483989 creator A5016111593 @default.
- W2044483989 creator A5057577594 @default.
- W2044483989 creator A5060024418 @default.
- W2044483989 creator A5067774048 @default.
- W2044483989 creator A5074479466 @default.
- W2044483989 creator A5078389632 @default.
- W2044483989 creator A5078648580 @default.
- W2044483989 date "2006-11-01" @default.
- W2044483989 modified "2023-09-27" @default.
- W2044483989 title "53 POSTER A phase II, multicenter, randomized clinical trial to evaluate the efficacy and safety of bevacizumab (Avastin®) in combination with either chemotherapy (docetaxel or pemetrexed) or erlotinib hydrochloride (Tarceva®) compared with chemotherapy alone for treatment of recurrent or refractory non-small cell lung cancer" @default.
- W2044483989 doi "https://doi.org/10.1016/s1359-6349(06)70059-3" @default.
- W2044483989 hasPublicationYear "2006" @default.
- W2044483989 type Work @default.
- W2044483989 sameAs 2044483989 @default.
- W2044483989 citedByCount "7" @default.
- W2044483989 crossrefType "journal-article" @default.
- W2044483989 hasAuthorship W2044483989A5008593691 @default.
- W2044483989 hasAuthorship W2044483989A5011327480 @default.
- W2044483989 hasAuthorship W2044483989A5013955755 @default.
- W2044483989 hasAuthorship W2044483989A5016111593 @default.
- W2044483989 hasAuthorship W2044483989A5057577594 @default.
- W2044483989 hasAuthorship W2044483989A5060024418 @default.
- W2044483989 hasAuthorship W2044483989A5067774048 @default.
- W2044483989 hasAuthorship W2044483989A5074479466 @default.
- W2044483989 hasAuthorship W2044483989A5078389632 @default.
- W2044483989 hasAuthorship W2044483989A5078648580 @default.
- W2044483989 hasConcept C159985019 @default.
- W2044483989 hasConcept C18747287 @default.
- W2044483989 hasConcept C191897082 @default.
- W2044483989 hasConcept C192562407 @default.
- W2044483989 hasConcept C19474535 @default.
- W2044483989 hasConcept C2779227376 @default.
- W2044483989 hasConcept C2781448156 @default.
- W2044483989 hasConcept C5335593 @default.
- W2044483989 hasConcept C71924100 @default.
- W2044483989 hasConcept C87976508 @default.
- W2044483989 hasConcept C8846229 @default.
- W2044483989 hasConceptScore W2044483989C159985019 @default.
- W2044483989 hasConceptScore W2044483989C18747287 @default.
- W2044483989 hasConceptScore W2044483989C191897082 @default.
- W2044483989 hasConceptScore W2044483989C192562407 @default.
- W2044483989 hasConceptScore W2044483989C19474535 @default.
- W2044483989 hasConceptScore W2044483989C2779227376 @default.
- W2044483989 hasConceptScore W2044483989C2781448156 @default.
- W2044483989 hasConceptScore W2044483989C5335593 @default.
- W2044483989 hasConceptScore W2044483989C71924100 @default.
- W2044483989 hasConceptScore W2044483989C87976508 @default.
- W2044483989 hasConceptScore W2044483989C8846229 @default.
- W2044483989 hasIssue "12" @default.
- W2044483989 hasLocation W20444839891 @default.
- W2044483989 hasOpenAccess W2044483989 @default.
- W2044483989 hasPrimaryLocation W20444839891 @default.
- W2044483989 hasRelatedWork W1966210901 @default.
- W2044483989 hasRelatedWork W2034517149 @default.
- W2044483989 hasRelatedWork W2352994553 @default.
- W2044483989 hasRelatedWork W2363126956 @default.
- W2044483989 hasRelatedWork W2374322044 @default.
- W2044483989 hasRelatedWork W2389072089 @default.
- W2044483989 hasRelatedWork W3046875484 @default.
- W2044483989 hasRelatedWork W3089681302 @default.
- W2044483989 hasRelatedWork W4221060116 @default.
- W2044483989 hasRelatedWork W4379535127 @default.
- W2044483989 hasVolume "4" @default.
- W2044483989 isParatext "false" @default.
- W2044483989 isRetracted "false" @default.
- W2044483989 magId "2044483989" @default.
- W2044483989 workType "article" @default.